The prognostic value of global DNA hypomethylation in cancer: A meta-analysis

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Li, Jinhui ^a,b   Huang, Qingyuan ^c   Zeng, Fangfang ^a   Li, Wenxue ^b   He, Zhini ^a   Chen, Wen ^a   Zhu, Wei ^b   Zhang, Bo ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SATELLITE; ALU ELEMENT; LONG INTERSPERSED NUCLEAR ELEMENT 1; REPETITIVE DNA; UNCLASSIFIED DRUG; DNA; SATELLITE DNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; DNA METHYLATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOME; GENOMIC INSTABILITY; HUMAN; LONG INTERSPERSED REPEAT; MAJOR CLINICAL STUDY; NEOPLASM; OVERALL SURVIVAL; PYROSEQUENCING; RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); ALU SEQUENCE; GENETIC EPIGENESIS; GENETICS; HUMAN GENOME; META ANALYSIS; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL;

ALU ELEMENTS; DNA METHYLATION; DNA, NEOPLASM; DNA, SATELLITE; EPIGENESIS, GENETIC; GENOME, HUMAN; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84906970275     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106290     Document Type: Article

References (54)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917.
2. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358:1148-1159.
3. McDermott U, Downing JR, Stratton MR (2011) Genomics and the continuum of cancer care. N Engl J Med 364:340-350.
4. Hartman M, Loy EY, Ku CS, Chia KS (2010) Molecular epidemiology and its current clinical use in cancer. Lancet 11:383-390.
5. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16:6-21.
6. Yoshida T, Yamashita S, Takamura-Enya T, Niwa T, Ando T, et al. (2011) Alu and Satalpha hypomethylation in Helicobacter pylori-infected gastric mucosae. Int J Cancer 128:33-39.
7. Ehrlich M (2009) DNA hypomethylation in cancer cells. Epigenomics 1:1750-1911.
8. Ohka F, Natsume A, Motomura K, Kishida Y, Kondo Y, et al. (2011) The Global DNA Methylation Surrogate LINE-1Methylation Is Correlated with MGMT Promoter Methylation and Is a Better Prognostic Factor for Glioma.
9. Saito K, Kawakami K, Matsumoto I, Oda M, Watanabe G, et al. (2010) Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer. Clin Cancer Res 16:2418-2426.
10. Zan X (2010) LINE-1methylation level as sociation with clinico Pathologic features and Prognosis in hepatocellular carcinoma. Shanghai Department of hepatobiliary surgery, Second Military Medical University East Hospital.
11. Bae JM, Shin SH, Kwon HJ, Park SY, Kook MC, et al. (2012) ALU and LINE-1 hypomethylations in multistep gastric carcinogenesis and their prognostic implications. Int J Cancer 131:1323-1331.
12. Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, et al. (2013) Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer. Br J Cancer 109:408-415.
13. Pattamadilok J, Huapai N, Rattanatanyong P, Vasurattana A, Triratanachat S, et al. (2008) LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer. Int J Gynecol Cancer 18:711-717.
14. Rhee YY, Kim MJ, Bae JM, Koh JM, Cho NY, et al. (2012) Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level. Ann Surg Oncol 19:3441-3448.
15. Stroup DF, Berlin JA (2000) Meta-analysis of Observational Studies in Epidemiology. JAMA 283:2008-2012.
16. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1-34.
17. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16.
18. Julian P T, Higgins S G T, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560.
19. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet 371:569-578.
20. Der Simonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188.
21. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
22. Fabris S, Bollati V, Agnelli L, Morabito F, Motta V, et al. (2011) Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. Epigenetics 6:188-194.
23. Furniss CS, Marsit CJ, Houseman EA, Eddy K, Kelsey KT (2008) Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 17:966-971.
24. Hoshimoto S, Kuo CT, Chong KK, Takeshima TL, Takei Y, et al. (2012) AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome. J Invest Dermatol 132:1689-1697.
25. Iwagami S, Baba Y, Watanabe M, Shigaki H, Miyake K, et al. (2013) LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. Ann Surg 257:449-455.
26. Nosho K, Kure S, Irahara N, Shima K, Baba Y, et al. (2009) A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 137:1609-1620 e1601-1603.
27. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, et al. (2008) A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 100:1734-1738.
28. Shigaki H, Baba Y, Watanabe M, Murata A, Iwagami S, et al. (2012) LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis. Gastric Cancer.
29. Sigalotti L, Fratta E, Bidoli E, Covre A, Parisi G, et al. (2011) Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients. J Transl Med 9:78.
30. van Hoesel AQ, van de Velde CJ, Kuppen PJ, Liefers GJ, Putter H, et al. (2012) Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study. Breast Cancer Res Treat 134:1103-1114.
31. Yuka Aoki MN, Suzuki H (2013) Genomic vulnerability to LINE-1 hypomethylationis a potential determinant of the clinicogenetic features of multiple myeloma. Genome Med 4.
32. Zhang C, Xu Y, Zhao J, Fan L, Jiang G, et al. (2011) Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma. Ann Surg Oncol 18:2373-2380.
33. Zhu ZZ, Sparrow D, Hou L, Tarantini L, Bollati V, et al. (2011) Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: the Normative Aging Study. Cancer Causes Control 22:437-447.
34. Belinsky SA, Snow SS, Nikula KJ, Finch GL, Tellez CS, et al. (2002) Aberrant Cp G isl and methylation of the p16INK4a and estrogen receptor genes in rat lung tumors induced by particulate carcinogens. Carcinogenesis: 335-339.
35. Hou L, Zhang X, Tarantini L, Nordio F, Bonzini M, et al. (2011) Ambient PM exposure and DNA methylation in tumor suppressor genes: a cross-sectional study. Part Fibre Toxicol 8:25.
36. Doi T, Puri P, McCann A, Bannigan J, Thompson J (2011) Epigenetic effect of cadmium on global de novo DNA hypomethylation in the cadmium-induced ventral body wall defect (VBWD) in the chick model. Toxicol Sci 120:475-480.
37. Intarasunanont P, Navasumrit P, Waraprasit S, Chaisatra K, Suk WA, et al. (2012) Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line. Intarasunanont et al Environmental Health 11.
38. Tao L, Wang W, Li L, Kramer PK, Pereira MA (2005) DNA hypomethylation induced by drinking water disinfection by-products in mouse and rat kidney. Toxicol Sci 87:344-352.
39. Duthie SJ, Narayanan S, Brand GM, Pirie L, Grant G (2002) Impact of folate deficiency on DNA stability. J Nutr.
40. Sincic N, Herceg Z (2011) DNA methylation and cancer: ghosts and angels above the genes. Curr Opin Oncol 23:69-76.
41. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, et al. (2002) DNMT1 and DNMT3b cooperate tosilence genes in human cancer cells. Nature 416:552-556.
42. Wilson AS, Power BE, Molloy PL (2007) DNA hypomethylation and human diseases. Biochim Biophys Acta 1775:138-162.
43. Wu H, Zhang Y (2011) Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev 25:2436-2452.
44. Sigalotti L, Covre A, Fratta E, Parisi G, Colizzi F, et al. (2010) Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies. J Transl Med 8:56.
45. Banelli B, Brigati C, Di Vinci A, Casciano I, Forlani A, et al. (2012) A pyrosequencing assay for the quantitative methylation analysis of the PCDHB gene cluster, the major factor in neuroblastoma methylator phenotype. Lab Invest 92:458-465.
46. Irahara N, Nosho K, Baba Y, Shima K, Lindeman NI, et al. (2010) Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. J Mol Diagn 12:177-183.
47. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, et al. (2004) Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23:8841-8846.
48. Ross JP, Rand KN, Molloy PL (2010) Hypomethylation of repeated DNA sequences in cancer. Epigenomics 2:245-269.
49. Aoki Y, Nojima M, Suzuki H, Yasui H, Maruyama R, et al. (2012) Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma. Genome Medicine 4.
50. Gilbert J, Gore SD, Herman JG, Carducci MA (2004) The Clinical Application of Targeting Cancer through Histone Acetylation and Hypomethylation. Clin Cancer Res 10:4589-4596.
51. Maio M, Coral S, Fratta E, Altomonte M, Sigalotti L (2003) Epigenetic targets for immune intervention in human malignancies. Oncogene 22:6484-6488.
52. Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, et al. (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 21:4592-4596.
53. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, et al. (2001) Chemoradiotherapy After Surgery Compared With Surgery Alone For Adenocarcinoma Of The Stomach Or Gastroesophageal Junction. N Engl J Med 345:725-730.
54. Klek S, Szybinski P, Szczepanek K (2013) Perioperative Immunonutrition in Surgical Cancer Patients: A Summary of a Decade of Research. World J Surg.